Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
PLoS Pathog ; 19(9): e1011182, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37713419

RESUMEN

The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells (RBCs). To trigger RBC invasion, PfRH5 engages with RBC protein basigin in a step termed the RH5-basigin binding stage. Although we know increasingly more about how antibodies specific for PfRH5 can block invasion, much less is known about how antibodies recognizing other members of the PCRCR complex can inhibit invasion. To address this, we performed live cell imaging using monoclonal antibodies (mAbs) which bind PfRH5 and PfCyRPA. We measured the degree and timing of the invasion inhibition, the stage at which it occurred, as well as subsequent events. We show that parasite invasion is blocked by individual mAbs, and the degree of inhibition is enhanced when combining a mAb specific for PfRH5 with one binding PfCyRPA. In addition to directly establishing the invasion-blocking capacity of the mAbs, we identified a secondary action of certain mAbs on extracellular parasites that had not yet invaded where the mAbs appeared to inactivate the parasites by triggering a developmental pathway normally only seen after successful invasion. These findings suggest that epitopes within the PfCyRPA-PfRH5 sub-complex that elicit these dual responses may be more effective immunogens than neighboring epitopes by both blocking parasites from invading and rapidly inactivating extracellular parasites. These two protective mechanisms, prevention of invasion and inactivation of uninvaded parasites, resulting from antibody to a single epitope indicate a possible route to the development of more effective vaccines.


Asunto(s)
Basigina , Merozoítos , Humanos , Animales , Plasmodium falciparum , Anticuerpos Monoclonales , Epítopos
2.
J Immunol ; 196(3): 1239-48, 2016 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-26700768

RESUMEN

The human complement system is the frontline defense mechanism against invading pathogens. The coexistence of humans and microbes throughout evolution has produced ingenious molecular mechanisms by which microorganisms escape complement attack. A common evasion strategy used by diverse pathogens is the hijacking of soluble human complement regulators to their surfaces to afford protection from complement activation. One such host regulator is factor H (FH), which acts as a negative regulator of complement to protect host tissues from aberrant complement activation. In this report, we show that Plasmodium falciparum merozoites, the invasive form of the malaria parasites, actively recruit FH and its alternative spliced form FH-like protein 1 when exposed to human serum. We have mapped the binding site in FH that recognizes merozoites and identified Pf92, a member of the six-cysteine family of Plasmodium surface proteins, as its direct interaction partner. When bound to merozoites, FH retains cofactor activity, a key function that allows it to downregulate the alternative pathway of complement. In P. falciparum parasites that lack Pf92, we observed changes in the pattern of C3b cleavage that are consistent with decreased regulation of complement activation. These results also show that recruitment of FH affords P. falciparum merozoites protection from complement-mediated lysis. Our study provides new insights on mechanisms of immune evasion of malaria parasites and highlights the important function of surface coat proteins in the interplay between complement regulation and successful infection of the host.


Asunto(s)
Activación de Complemento/inmunología , Factor H de Complemento/inmunología , Evasión Inmune/inmunología , Malaria Falciparum/inmunología , Western Blotting , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Humanos , Inmunoprecipitación , Merozoítos/inmunología
3.
PLoS Pathog ; 11(12): e1005343, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26694741

RESUMEN

The most severe form of malaria in humans is caused by the protozoan parasite Plasmodium falciparum. The invasive form of malaria parasites is termed a merozoite and it employs an array of parasite proteins that bind to the host cell to mediate invasion. In Plasmodium falciparum, the erythrocyte binding-like (EBL) and reticulocyte binding-like (Rh) protein families are responsible for binding to specific erythrocyte receptors for invasion and mediating signalling events that initiate active entry of the malaria parasite. Here we have addressed the role of the cytoplasmic tails of these proteins in activating merozoite invasion after receptor engagement. We show that the cytoplasmic domains of these type 1 membrane proteins are phosphorylated in vitro. Depletion of PfCK2, a kinase implicated to phosphorylate these cytoplasmic tails, blocks P. falciparum invasion of red blood cells. We identify the crucial residues within the PfRh4 cytoplasmic domain that are required for successful parasite invasion. Live cell imaging of merozoites from these transgenic mutants show they attach but do not penetrate erythrocytes implying the PfRh4 cytoplasmic tail conveys signals important for the successful completion of the invasion process.


Asunto(s)
Eritrocitos/microbiología , Malaria Falciparum/metabolismo , Fosfotransferasas/metabolismo , Plasmodium falciparum/metabolismo , Proteínas Protozoarias/metabolismo , Secuencia de Aminoácidos , Humanos , Merozoítos/metabolismo , Datos de Secuencia Molecular , Fosforilación , Plasmodium falciparum/patogenicidad
4.
PLoS Pathog ; 11(2): e1004670, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25723550

RESUMEN

During blood stage Plasmodium falciparum infection, merozoites invade uninfected erythrocytes via a complex, multistep process involving a series of distinct receptor-ligand binding events. Understanding each element in this process increases the potential to block the parasite's life cycle via drugs or vaccines. To investigate specific receptor-ligand interactions, they were systematically blocked using a combination of genetic deletion, enzymatic receptor cleavage and inhibition of binding via antibodies, peptides and small molecules, and the resulting temporal changes in invasion and morphological effects on erythrocytes were filmed using live cell imaging. Analysis of the videos have shown receptor-ligand interactions occur in the following sequence with the following cellular morphologies; 1) an early heparin-blockable interaction which weakly deforms the erythrocyte, 2) EBA and PfRh ligands which strongly deform the erythrocyte, a process dependant on the merozoite's actin-myosin motor, 3) a PfRh5-basigin binding step which results in a pore or opening between parasite and host through which it appears small molecules and possibly invasion components can flow and 4) an AMA1-RON2 interaction that mediates tight junction formation, which acts as an anchor point for internalization. In addition to enhancing general knowledge of apicomplexan biology, this work provides a rational basis to combine sequentially acting merozoite vaccine candidates in a single multi-receptor-blocking vaccine.


Asunto(s)
Eritrocitos/parasitología , Interacciones Huésped-Parásitos , Malaria Falciparum/sangre , Malaria Falciparum/parasitología , Plasmodium falciparum/patogenicidad , Receptores de Superficie Celular/metabolismo , Animales , Antígenos de Protozoos/metabolismo , Basigina/metabolismo , Calcio/metabolismo , Proteínas Portadoras/metabolismo , Forma de la Célula , Células Cultivadas , Eritrocitos/metabolismo , Eritrocitos/patología , Interacciones Huésped-Parásitos/fisiología , Ligandos , Malaria Falciparum/metabolismo , Proteínas de la Membrana/metabolismo , Merozoítos/metabolismo , Merozoítos/patología , Plasmodium falciparum/metabolismo , Unión Proteica , Proteínas Protozoarias/metabolismo , Conejos , Transducción de Señal
5.
Org Biomol Chem ; 14(20): 4617-39, 2016 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-27105169

RESUMEN

Central to malaria pathogenesis is the invasion of human red blood cells by Plasmodium falciparum parasites. Following each cycle of intracellular development and replication, parasites activate a cellular program to egress from their current host cell and invade a new one. The orchestration of this process critically relies upon numerous organised phospho-signaling cascades, which are mediated by a number of central kinases. Parasite kinases are emerging as novel antimalarial targets as they have diverged sufficiently from their mammalian counterparts to allow selectable therapeutic action. Parasite protein kinase A (PfPKA) is highly expressed late in the cell cycle of the parasite blood stage and has been shown to phosphorylate a critical invasion protein, Apical Membrane Antigen 1. This enzyme could therefore be a valuable drug target so we have repurposed a substituted 4-cyano-3-methylisoquinoline that has been shown to inhibit rat PKA with the goal of targeting PfPKA. We synthesised a novel series of compounds and, although many potently inhibit the growth of chloroquine sensitive and resistant strains of P. falciparum, they were found to have minimal activity against PfPKA, indicating that they likely have another target important to parasite cytokinesis and invasion.


Asunto(s)
Antimaláricos/síntesis química , Antimaláricos/farmacología , Diseño de Fármacos , Isoquinolinas/síntesis química , Isoquinolinas/farmacología , Plasmodium falciparum/efectos de los fármacos , Secuencia de Aminoácidos , Antimaláricos/química , Técnicas de Química Sintética , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Proteínas Quinasas Dependientes de AMP Cíclico/química , Evaluación Preclínica de Medicamentos , Isoquinolinas/química , Plasmodium falciparum/enzimología , Plasmodium falciparum/crecimiento & desarrollo
6.
BMC Biol ; 13: 52, 2015 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-26187647

RESUMEN

BACKGROUND: Malaria invasion of red blood cells involves multiple parasite-specific targets that are easily accessible to inhibitory compounds, making it an attractive target for antimalarial development. However, no current antimalarial agents act against host cell invasion. RESULTS: Here, we demonstrate that the clinically used macrolide antibiotic azithromycin, which is known to kill human malaria asexual blood-stage parasites by blocking protein synthesis in their apicoplast, is also a rapid inhibitor of red blood cell invasion in human (Plasmodium falciparum) and rodent (P. berghei) malarias. Multiple lines of evidence demonstrate that the action of azithromycin in inhibiting parasite invasion of red blood cells is independent of its inhibition of protein synthesis in the parasite apicoplast, opening up a new strategy to develop a single drug with multiple parasite targets. We identified derivatives of azithromycin and erythromycin that are better invasion inhibitors than parent compounds, offering promise for development of this novel antimalarial strategy. CONCLUSIONS: Safe and effective macrolide antibiotics with dual modalities could be developed to combat malaria and reduce the parasite's options for resistance.


Asunto(s)
Antimaláricos/farmacología , Azitromicina/farmacología , Eritrocitos/parasitología , Eritromicina/farmacología , Malaria/tratamiento farmacológico , Plasmodium berghei/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Animales , Anopheles , Antimaláricos/química , Azitromicina/química , Eritromicina/química , Interacciones Huésped-Parásitos/efectos de los fármacos , Humanos , Malaria/parasitología , Ratones , Plasmodium berghei/fisiología , Plasmodium falciparum/fisiología
7.
Cell Microbiol ; 16(5): 642-56, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24571085

RESUMEN

Malaria is caused by obligate intracellular parasites, of which Plasmodium falciparum is the most lethal species. In humans, P. falciparum merozoites (invasive forms of the parasite) employ a host of parasite proteins to rapidly invade erythrocytes. One of these is the P. falciparum apical membrane antigen 1 (PfAMA1) which forms a complex with rhoptry neck proteins at the tight junction. Here, we have placed the Pfama1 gene under conditional control using dimerizable Cre recombinase (DiCre) in P. falciparum. DiCre-mediated excision of the loxP-flanked Pfama1 gene results in approximately 80% decreased expression of the protein within one intraerythrocytic growth cycle. This reduces growth by 40%, due to decreased invasion efficiency characterized by a post-invasion defect in sealing of the parasitophorous vacuole. These results show that PfAMA1 is an essential protein for merozoite invasion in P. falciparum and either directly or indirectly plays a role in resealing of the red blood cell at the posterior end of the invasion event.


Asunto(s)
Antígenos de Protozoos/metabolismo , Endocitosis , Eritrocitos/parasitología , Proteínas de la Membrana/metabolismo , Merozoítos/fisiología , Plasmodium falciparum/fisiología , Proteínas Protozoarias/metabolismo , Vacuolas/parasitología , Antígenos de Protozoos/genética , Expresión Génica , Proteínas de la Membrana/genética , Biología Molecular , Plasmodium falciparum/genética , Plasmodium falciparum/crecimiento & desarrollo , Proteínas Protozoarias/genética , Recombinación Genética
8.
J Immunol ; 189(6): 2746-57, 2012 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-22875803

RESUMEN

HIV type 1 (HIV-1) replicates preferentially in IL-4-producing CD4 T cells for unclear reasons. We show increased HIV-1 expression is irrespective of viral tropism for chemokine receptors as previously suggested, but rather transcription of the HIV-1 long terminal repeat (LTR) is increased in IL-4-producing CD4 T cells. Increased expression of HIV-1 message is also confirmed in IL-4-producing CD4 T cells from HIV-1-infected individuals ex vivo. In exploring a transcriptional mechanism, we identify a novel c-maf (required for IL-4 expression) transcription factor binding site just upstream of the dual NF-κB/NFAT binding sites in the proximal HIV-1 LTR. We demonstrate that c-maf binds this site in vivo and synergistically augments HIV-1 transcription in cooperation with NFAT2 and NF-κB p65, but not NFAT1 or NF-κB p50. Conversely, small interfering RNA inhibition of c-maf reduces HIV-1 transcription in IL-4-producing T cells. Thus, c-maf increases HIV-1 expression in IL-4-producing CD4 T cells by binding the proximal HIV-1 LTR and augmenting HIV-1 transcription in partnership with NFAT2 and NF-κB p65 specifically. This has important implications for selective targeting of transcription factors during HIV-1 infection because, over the course of HIV-1 progression/AIDS, IL-4-producing T cells frequently predominate and substantially contribute to disease pathology.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Regulación Viral de la Expresión Génica/inmunología , VIH-1/genética , Interleucina-4/biosíntesis , Proteínas Proto-Oncogénicas c-maf/fisiología , Transcripción Genética/inmunología , Replicación Viral/inmunología , Linfocitos T CD4-Positivos/metabolismo , Regulación hacia Abajo/inmunología , VIH-1/inmunología , Humanos , Unión Proteica/genética , Unión Proteica/inmunología , Proteínas Proto-Oncogénicas c-maf/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-maf/genética , Regulación hacia Arriba/inmunología , Latencia del Virus/inmunología
9.
Proc Natl Acad Sci U S A ; 107(15): 6958-63, 2010 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-20351286

RESUMEN

Abs are central to malaria immunity, which is only acquired after years of exposure to Plasmodium falciparum (Pf). Despite the enormous worldwide burden of malaria, the targets of protective Abs and the basis of their inefficient acquisition are unknown. Addressing these knowledge gaps could accelerate malaria vaccine development. To this end, we developed a protein microarray containing approximately 23% of the Pf 5,400-protein proteome and used this array to probe plasma from 220 individuals between the ages of 2-10 years and 18-25 years in Mali before and after the 6-month malaria season. Episodes of malaria were detected by passive surveillance over the 8-month study period. Ab reactivity to Pf proteins rose dramatically in children during the malaria season; however, most of this response appeared to be short-lived based on cross-sectional analysis before the malaria season, which revealed only modest incremental increases in Ab reactivity with age. Ab reactivities to 49 Pf proteins measured before the malaria season were significantly higher in 8-10-year-old children who were infected with Pf during the malaria season but did not experience malaria (n = 12) vs. those who experienced malaria (n = 29). This analysis also provided insight into patterns of Ab reactivity against Pf proteins based on the life cycle stage at which proteins are expressed, subcellular location, and other proteomic features. This approach, if validated in larger studies and in other epidemiological settings, could prove to be a useful strategy for better understanding fundamental properties of the human immune response to Pf and for identifying previously undescribed vaccine targets.


Asunto(s)
Malaria Falciparum/inmunología , Plasmodium falciparum/metabolismo , Análisis por Matrices de Proteínas/métodos , Adolescente , Adulto , Animales , Antígenos de Protozoos/inmunología , Niño , Preescolar , Estudios de Cohortes , Humanos , Sistema Inmunológico , Vacunas contra la Malaria/química , Malí , Proteómica/métodos
10.
Infect Immun ; 80(4): 1583-92, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22252876

RESUMEN

The development of clinical immunity to Plasmodium falciparum malaria is thought to require years of parasite exposure, a delay often attributed to difficulties in developing protective antibody levels. In this study, we evaluated several P. falciparum vaccine candidate antigens, including apical membrane antigen 1 (AMA-1), circumsporozoite protein (CSP), erythrocyte binding antigen 175 (EBA-175), and the 19-kDa region of merozoite surface protein 1 (MSP1(19)). After observing a more robust antibody response to MSP1(19), we evaluated the magnitude and longevity of IgG responses specific to this antigen in Peruvian adults and children before, during, and after P. falciparum infection. In this low-transmission region, even one reported prior infection was sufficient to produce a positive anti-MSP1(19) IgG response for >5 months in the absence of reinfection. We also observed an expansion of the total plasmablast (CD19(+) CD27(+) CD38(high)) population in the majority of individuals shortly after infection and detected MSP1-specific memory B cells in a subset of individuals at various postinfection time points. This evidence supports our hypothesis that effective antimalaria humoral immunity can develop in low-transmission regions.


Asunto(s)
Memoria Inmunológica , Malaria Falciparum/inmunología , Proteína 1 de Superficie de Merozoito/inmunología , Plasmodium falciparum/inmunología , ADP-Ribosil Ciclasa 1/biosíntesis , Adolescente , Adulto , Anticuerpos Antiprotozoarios/sangre , Anticuerpos Antiprotozoarios/inmunología , Antígenos CD19/biosíntesis , Antígenos de Protozoos/inmunología , Linfocitos B/inmunología , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/inmunología , Vacunas contra la Malaria/inmunología , Malaria Falciparum/epidemiología , Malaria Falciparum/transmisión , Masculino , Proteínas de la Membrana/inmunología , Perú/epidemiología , Proteínas Protozoarias/inmunología , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/biosíntesis , Adulto Joven
11.
PLoS Pathog ; 6(5): e1000912, 2010 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-20502681

RESUMEN

Immunity to Plasmodium falciparum (Pf) malaria is only acquired after years of repeated infections and wanes rapidly without ongoing parasite exposure. Antibodies are central to malaria immunity, yet little is known about the B-cell biology that underlies the inefficient acquisition of Pf-specific humoral immunity. This year-long prospective study in Mali of 185 individuals aged 2 to 25 years shows that Pf-specific memory B-cells and antibodies are acquired gradually in a stepwise fashion over years of repeated Pf exposure. Both Pf-specific memory B cells and antibody titers increased after acute malaria and then, after six months of decreased Pf exposure, contracted to a point slightly higher than pre-infection levels. This inefficient, stepwise expansion of both the Pf-specific memory B-cell and long-lived antibody compartments depends on Pf exposure rather than age, based on the comparator response to tetanus vaccination that was efficient and stable. These observations lend new insights into the cellular basis of the delayed acquisition of malaria immunity.


Asunto(s)
Linfocitos B/inmunología , Linfocitos B/parasitología , Memoria Inmunológica/inmunología , Malaria Falciparum/inmunología , Plasmodium falciparum/inmunología , Enfermedad Aguda , Adolescente , Adulto , Anticuerpos Antiprotozoarios/sangre , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunofenotipificación , Estudios Longitudinales , Malaria Falciparum/transmisión , Masculino , Malí , Estudios Prospectivos , Recurrencia , Estaciones del Año , Adulto Joven
12.
J Immunol ; 183(3): 2176-82, 2009 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-19592645

RESUMEN

Epidemiological observations in malaria endemic areas have long suggested a deficiency in the generation and maintenance of B cell memory to Plasmodium falciparum (Pf) in individuals chronically reinfected with the parasite. Recently, a functionally and phenotypically distinct population of FCRL4(+) hyporesponsive memory B cells (MBCs) was reported to be expanded in HIV-infected individuals with high viral loads. In this study, we provide evidence that a phenotypically similar atypical MBC population is significantly expanded in Pf-exposed Malian adults and children as young as 2 years of age as compared with healthy U.S. adult controls. The number of these atypical MBCs was higher in children with chronic asymptomatic Pf infections compared with uninfected children, suggesting that the chronic presence of the parasite may drive expansion of these distinct MBCs. This is the first description of an atypical MBC phenotype associated with malaria. Understanding the origin and function of these MBCs could be important in informing the design of malaria vaccines.


Asunto(s)
Linfocitos B/inmunología , Memoria Inmunológica , Malaria/inmunología , Receptores Fc/análisis , Adolescente , Adulto , Animales , Estudios de Casos y Controles , Proliferación Celular , Niño , Preescolar , Enfermedades Endémicas , Humanos , Inmunofenotipificación , Malaria/epidemiología , Plasmodium falciparum/inmunología , Adulto Joven
13.
J Immunol ; 182(5): 3318-26, 2009 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19234231

RESUMEN

Despite the central role of memory B cells (MBC) in protective immune responses, little is understood about how they are acquired in naive individuals in response to Ag exposure, and how this process is influenced by concurrent activation of the innate immune system's TLR. In this longitudinal study of malaria-naive individuals, we examined the MBC response to two candidate malaria vaccines administered with or without CpG, a TLR9 ligand. We show that the acquisition of MBC is a dynamic process in which the vaccine-specific MBC pool rapidly expands and then contracts, and that CpG enhances the kinetics, magnitude, and longevity of this response. We observed that the percentage of vaccine-specific MBC present at the time of reimmunization predicts vaccine-specific Ab levels 14 days later; and that at steady-state, there is a positive correlation between vaccine-specific MBC and Ab levels. An examination of the total circulating MBC and plasma cell pools also suggests that MBC differentiate into plasma cells through polyclonal activation, independent of Ag specificity. These results provide important insights into the human MBC response, which can inform the development of vaccines against malaria and other pathogens that disrupt immunological memory.


Asunto(s)
Subgrupos de Linfocitos B/inmunología , Memoria Inmunológica , Malaria/inmunología , Oligodesoxirribonucleótidos/administración & dosificación , Plasmodium falciparum/inmunología , Receptor Toll-Like 9/administración & dosificación , Adyuvantes Inmunológicos/administración & dosificación , Adulto , Hidróxido de Aluminio/administración & dosificación , Hidróxido de Aluminio/inmunología , Animales , Subgrupos de Linfocitos B/metabolismo , Células Cultivadas , Ensayos Clínicos Fase I como Asunto , Islas de CpG/inmunología , Epítopos de Linfocito B/inmunología , Humanos , Inmunización Secundaria , Ligandos , Vacunas contra la Malaria/administración & dosificación , Vacunas contra la Malaria/inmunología , Oligodesoxirribonucleótidos/metabolismo , Receptor Toll-Like 9/metabolismo
14.
Infect Immun ; 78(2): 737-45, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19917712

RESUMEN

Immunity to the asexual blood stage of Plasmodium falciparum is complex and likely involves several effector mechanisms. Antibodies are thought to play a critical role in malaria immunity, and a corresponding in vitro correlate of antibody-mediated immunity has long been sought to facilitate malaria vaccine development. The growth inhibition assay (GIA) measures the capacity of antibodies to limit red blood cell (RBC) invasion and/or growth of P. falciparum in vitro. In humans, naturally acquired and vaccine-induced P. falciparum-specific antibodies have growth-inhibitory activity, but it is unclear if growth-inhibitory activity correlates with protection from clinical disease. In a longitudinal study in Mali, purified IgGs, obtained from plasmas collected before the malaria season from 220 individuals aged 2 to 10 and 18 to 25 years, were assayed for growth-inhibitory activity. Malaria episodes were recorded by passive surveillance over the subsequent 6-month malaria season. Logistic regression showed that greater age (odds ratio [OR], 0.78; 95% confidence interval [95% CI], 0.63 to 0.95; P = 0.02) and growth-inhibitory activity (OR, 0.50; 95% CI, 0.30 to 0.85; P = 0.01) were significantly associated with decreased malaria risk in children. A growth-inhibitory activity level of 40% was determined to be the optimal cutoff for discriminating malaria-immune and susceptible individuals in this cohort, with a sensitivity of 97.0%, but a low specificity of 24.3%, which limited the assay's ability to accurately predict protective immunity and to serve as an in vitro correlate of antibody-mediated immunity. These data suggest that antibodies which block merozoite invasion of RBC and/or inhibit the intra-RBC growth of the parasite contribute to but are not sufficient for the acquisition of malaria immunity.


Asunto(s)
Anticuerpos Antiprotozoarios/inmunología , Malaria/inmunología , Adolescente , Adulto , Niño , Preescolar , Estudios de Cohortes , Femenino , Pruebas Hematológicas/métodos , Humanos , Inmunoglobulina G/inmunología , Técnicas In Vitro , Masculino , Malí , Plasmodium malariae/inmunología , Riesgo , Adulto Joven
15.
Int J Parasitol ; 50(3): 235-252, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32135179

RESUMEN

With emerging resistance to frontline treatments, it is vital that new drugs are identified to target Plasmodium falciparum. One of the most critical processes during parasites asexual lifecycle is the invasion and subsequent egress of red blood cells (RBCs). Many unique parasite ligands, receptors and enzymes are employed during egress and invasion that are essential for parasite proliferation and survival, therefore making these processes druggable targets. To identify potential inhibitors of egress and invasion, we screened the Medicines for Malaria Venture Pathogen Box, a 400 compound library against neglected tropical diseases, including 125 with antimalarial activity. For this screen, we utilised transgenic parasites expressing a bioluminescent reporter, nanoluciferase (Nluc), to measure inhibition of parasite egress and invasion in the presence of the Pathogen Box compounds. At a concentration of 2 µM, we found 15 compounds that inhibited parasite egress by >40% and 24 invasion-specific compounds that inhibited invasion by >90%. We further characterised 11 of these inhibitors through cell-based assays and live cell microscopy, and found two compounds that inhibited merozoite maturation in schizonts, one compound that inhibited merozoite egress, one compound that directly inhibited parasite invasion and one compound that slowed down invasion and arrested ring formation. The remaining compounds were general growth inhibitors that acted during the egress and invasion phase of the cell cycle. We found the sulfonylpiperazine, MMV020291, to be the most invasion-specific inhibitor, blocking successful merozoite internalisation within human RBCs and having no substantial effect on other stages of the cell cycle. This has significant implications for the possible development of an invasion-specific inhibitor as an antimalarial in a combination based therapy, in addition to being a useful tool for studying the biology of the invading parasite.


Asunto(s)
Antimaláricos/farmacología , Evaluación Preclínica de Medicamentos , Plasmodium falciparum/efectos de los fármacos , Animales , Eritrocitos/parasitología , Humanos , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/parasitología , Merozoítos/efectos de los fármacos , Piperazina , Piperazinas/farmacología , Plasmodium falciparum/crecimiento & desarrollo , Plasmodium falciparum/metabolismo , Esquizontes/efectos de los fármacos
16.
Elife ; 62017 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-28252383

RESUMEN

Plasmodium falciparum parasites, the causative agents of malaria, modify their host erythrocyte to render them permeable to supplementary nutrient uptake from the plasma and for removal of toxic waste. Here we investigate the contribution of the rhoptry protein RhopH2, in the formation of new permeability pathways (NPPs) in Plasmodium-infected erythrocytes. We show RhopH2 interacts with RhopH1, RhopH3, the erythrocyte cytoskeleton and exported proteins involved in host cell remodeling. Knockdown of RhopH2 expression in cycle one leads to a depletion of essential vitamins and cofactors and decreased de novo synthesis of pyrimidines in cycle two. There is also a significant impact on parasite growth, replication and transition into cycle three. The uptake of solutes that use NPPs to enter erythrocytes is also reduced upon RhopH2 knockdown. These findings provide direct genetic support for the contribution of the RhopH complex in NPP activity and highlight the importance of NPPs to parasite survival.


Asunto(s)
Eritrocitos/parasitología , Interacciones Huésped-Patógeno , Plasmodium falciparum/crecimiento & desarrollo , Plasmodium falciparum/metabolismo , Proteínas Protozoarias/metabolismo , Animales , Citoesqueleto/metabolismo , Humanos , Ratones , Pirimidinas/metabolismo , Vitaminas/metabolismo
17.
Trends Parasitol ; 32(4): 284-295, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26778295

RESUMEN

A highly-effective, long-lasting vaccine, targeting multiple stages of the Plasmodium falciparum life cycle, is likely to be important for the elimination of this pathogen. Key antigens of this vaccine would produce host antibodies that block the ligands required for merozoite invasion of erythrocytes, thereby curtailing the expansion of parasitemia and symptomatic disease. Recent live cell imaging of invading Plasmodium falciparum merozoites with various receptor-ligand interactions inhibited has provided new information about the function, sequence, and timing of these events, providing a rationale for a vaccine containing multiple antigens that inhibit the sequential steps of invasion.


Asunto(s)
Eritrocitos/parasitología , Malaria Falciparum/fisiopatología , Plasmodium falciparum/fisiología , Humanos , Estadios del Ciclo de Vida/fisiología , Ligandos , Vacunas contra la Malaria/normas , Plasmodium falciparum/genética , Proteínas Protozoarias/genética
18.
J Immunol Methods ; 408: 123-31, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24910411

RESUMEN

Gene transfer into primary human CD4 T lymphocytes is a critical tool in studying the mechanism of T cell-dependent immune responses and human immunodeficiency virus-1 (HIV-1) infection. Nucleofection® is an electroporation technique that allows efficient gene transfer into primary human CD4 T cells that are notoriously resistant to traditional electroporation. Despite its popularity in immunological research, careful characterization of its impact on the physiology of CD4 T cells has not been documented. Herein, using freshly-isolated primary human CD4 T cells, we examine the effects of Nucleofection® on CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity. We find that immediately after Nucleofection®, CD4 T cells undergo dramatic morphological changes characterized by wrinkled and dilated plasma membranes before recovering 1h later. The intracellular calcium level also increases after Nucleofection®, peaking after 1h before recovering 8h post transfection. Moreover, Nucleofection® leads to increased expression of T cell activation markers, CD154 and CD69, for more than 24h, and enhances the activation effects of phytohemagglutinin (PHA) stimulation. In addition, transcriptional activity is increased in the first 24h after Nucleofection®, even in the absence of exogenous stimuli. Therefore, Nucleofection® significantly alters the activation state of primary human CD4 T cells. The effect of transferred gene products on CD4 T cell function by Nucleofection® should be assessed after sufficient resting time post transfection or analyzed in light of the activation caveats mentioned above.


Asunto(s)
Linfocitos T CD4-Positivos/metabolismo , Electroporación , Activación de Linfocitos , Transfección/métodos , Antígenos CD/metabolismo , Antígenos de Diferenciación de Linfocitos T/metabolismo , Linfocitos T CD4-Positivos/inmunología , Ligando de CD40/metabolismo , Calcio/metabolismo , Forma de la Célula , Células Cultivadas , Regulación de la Expresión Génica , Genes Reporteros , Antígenos HLA-DR/metabolismo , Humanos , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Lectinas Tipo C/metabolismo , Cultivo Primario de Células , Factores de Tiempo , Transcripción Genética
19.
J Immunol Methods ; 375(1-2): 68-74, 2012 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-21963949

RESUMEN

Memory B cells (MBCs) are a key component of long term humoral immunity to many human infectious diseases. Despite their importance, we know little about the generation or maintenance of antigen-(Ag)-specific MBCs in humans in response to infection. A frequently employed method for quantifying Ag-specific MBCs in human peripheral blood (Crotty et al., 2004) relies on the ability of MBCs but not naïve B cells to differentiate into antibody secreting cells (ASCs) in response to polyclonal activators and Toll-like receptor agonists in vitro and the measurement of Ag-specific ASCs by ELISPOT assays. Here we report on studies to optimize the efficiency of this ELISPOT-based assay and to apply this assay to the detection of Plasmodium falciparum (Pf)-specific MBCs in adults living in a malaria endemic area where immunity to Pf is acquired through natural infection. We show that the addition of IL-10 to in vitro cultures of human peripheral blood mononuclear cells increased the efficiency of the assay from 10% to over 90% without increasing the ASC burst size and without any substantial increase in background from naïve B cells or plasma cells (PCs). Using this assay we were able to quantify the frequency of Pf-specific MBCs in peripheral blood of adults living in a malaria endemic area. Thus, this highly efficient assay appears to be well suited to field studies of the generation and maintenance of MBCs where the volumes of blood obtainable are often limiting.


Asunto(s)
Linfocitos B/inmunología , Ensayo de Immunospot Ligado a Enzimas/métodos , Epítopos de Linfocito B/inmunología , Memoria Inmunológica/inmunología , Plasmodium falciparum/inmunología , Células Productoras de Anticuerpos/inmunología , Citometría de Flujo/métodos , Humanos , Interleucina-10/inmunología , Leucocitos Mononucleares/inmunología , Malaria/inmunología , Células Plasmáticas/inmunología
20.
PLoS One ; 6(1): e15983, 2011 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-21264245

RESUMEN

BACKGROUND: Antibodies that protect against Plasmodium falciparum (Pf) malaria are only acquired after years of repeated infections. The B cell biology that underlies this observation is poorly understood. We previously reported that "atypical" memory B cells are increased in children and adults exposed to intense Pf transmission in Mali, similar to what has been observed in individuals infected with HIV. In this study we examined B cell subsets of Pf -infected adults in Peru and Mali to determine if Pf transmission intensity correlates with atypical memory B cell expansion. METHODOLOGY/PRINCIPAL FINDINGS: In this cross-sectional study venous blood was collected from adults in areas of zero (U.S., n = 10), low (Peru, n = 18) and high (Mali, n = 12) Pf transmission. Adults in Peru and Mali were infected with Pf at the time of blood collection. Thawed lymphocytes were analyzed by flow cytometry to quantify B cell subsets, including atypical memory B cells, defined by the cell surface markers CD19(+) CD20(+) CD21(-) CD27(-) CD10(-). In Peru, the mean level of atypical memory B cells, as a percent of total B cells, was higher than U.S. adults (Peru mean: 5.4% [95% CI: 3.61-7.28]; U.S. mean: 1.4% [95% CI: 0.92-1.81]; p<0.0001) but lower than Malian adults (Mali mean 13.1% [95% CI: 10.68-15.57]; p = 0.0001). In Peru, individuals self-reporting ≥1 prior malaria episodes had a higher percentage of atypical memory B cells compared to those reporting no prior episodes (≥1 prior episodes mean: 6.6% [95% CI: 4.09-9.11]; no prior episodes mean: 3.1% [95% CI: 1.52-4.73]; p = 0.028). CONCLUSIONS/SIGNIFICANCE: Compared to Pf-naive controls, atypical memory B cells were increased in Peruvian adults exposed to low Pf transmission, and further increased in Malian adults exposed to intense Pf transmission. Understanding the origin, function and antigen specificity of atypical memory B cells in the context of Pf infection could contribute to our understanding of naturally-acquired malaria immunity.


Asunto(s)
Linfocitos B/inmunología , Memoria Inmunológica , Malaria Falciparum/inmunología , Malaria Falciparum/transmisión , Adulto , Anciano , Antígenos CD/sangre , Linfocitos B/parasitología , Estudios Transversales , Femenino , Citometría de Flujo , Humanos , Recuento de Linfocitos , Malaria Falciparum/epidemiología , Masculino , Malí/epidemiología , Persona de Mediana Edad , Perú/epidemiología , Recurrencia , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA